1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Key Pharma News 16 FEBRUARY 2015

Key Pharma News 16 FEBRUARY 2015

  • February 2015
  • -
  • Espicom Business Intelligence
  • -
  • 41 pages

Industry Trend Analysis - New Compounds Fill Pipelines As R&D Expenditure Rises
Industry Trend Analysis - Genzyme/Voyager Deal Demonstrates Gene Therapy's Revival
Industry Trend Analysis - Hospira Eyes Up Lucentis Biosimilar In Deal That Will Threaten Roche/Novartis
Industry Trend Analysis - Acquisition Of Hospira Gives Pfizer Entrance To Biosimilar And Medical Device Markets
Industry Trend Analysis - Further Double-Digit Revenue Growth And Increased EPS For Biogen Idec In 2015
Industry Trend Analysis - AstraZeneca Further Bolsters Respiratory Portfolio
Industry Brief - GSK Receives EU Approval For Three-Part Transaction With Novartis
Industry Brief - AstraZeneca Gains Planning Consent For Global R&D Centre/Corporate HQ In Cambridge
Industry Trend Analysis - Novartis Under Pressure To Maximise Revenue Growth Of GSK's Oncology Portfolio
Industry Trend Analysis - Valeant Uses Cheap Acquisition To Enter Cancer Market
Industry Brief - Endo Completes Auxilium Acquisition
Industry Trend Analysis - GSK Strengthens Early Stage Vaccine Pipeline With GlycoVaxyn Acquisition
Industry Trend Analysis - Mylan's Acquisition Of Abbott's Non-US Generics Business On Track To Complete In Q115
Industry Trend Analysis - Regional Powerhouse Ahead As Sun/Ranbaxy Merger Approaches Conclusion
Industry Brief - Mylan To Acquire Famy Care
Industry Trend Analysis - Pfizer's Approval In BC Set To Give Positive Stroke To Company's Declining Revenues
Industry Brief - FDA Approves Prezcobix For HIV-1
Industry Trend Analysis - Zohydro ER's Abuse-Deterrent Label Delay Will Benefit Purdue
Industry Brief - EC Approves Velcade For MCL
Industry Brief - FDA Approves Imbruvica For WM
Industry Brief - Merck Repatriates Diabetes/Thyroids Portfolio In Russia
Industry Brief - Vyvanse Becomes First FDA-Approved Treatment For Moderate-To-Severe BED In Adults
Industry Brief - FDA Approves First-In-Class Glyxambi For Adults With Type II Diabetes
Industry Brief - FDA Grants Priority Review For Yondelis In Advanced STS
Industry Trend Analysis - Afrezza's US Launch Will Test Appetite For New Insulin Delivery Systems
Industry Trend Analysis - Merck's New Insomnia Medicine Has Limited Commercial Potential
Industry Brief - FDA Approves Lucentis For DR In Patients With DMO
Industry Brief - Chugai Submits Ibandronate NDA In Japan For Osteoporosis
Industry Trend Analysis - US Generic Sorafenib Revenues Will Be Small, But Global Prospects Are Attractive
Industry Brief - Breckenridge Initiates Cabazitaxel Patent Challenge
Industry Trend Analysis - As Biosimilar Adalimumab Progresses, Amgen And AbbVie's Fortunes Cast In Comparative Light
Industry Brief - AbbVie Reports Positive Results From Phase III Study Of All-Oral HCV Treatment In Japan
Industry Trend Analysis - FDA Turns Its Back On Merck For HCV; Repercussions For Achillion
Industry Trend Analysis - Neupro's Expansion Into China Will Boost UCB's Revenues
Industry Brief - FDA Grants Breakthrough Therapy Designation To Genentech's Anti-PDL1 Immunotherapy
Industry Brief - Enrolment Begins In Daiichi Sankyo's Mirogabalin Phase III Programmes
Industry Trend Analysis - Positive Phase II Results Could Lead To Daratumumab's Early Approval
Industry Trend Analysis - Takeda Can Replicate Velcade's Success With Ixazomib
Industry Trend Analysis - Gazyva Likely To Gain NHL Indication Just Ahead Of Vast Increase In Market Size
Industry Trend Analysis - Precision Medicine Initiative Promotes Data-Driven Treatment

Table Of Contents

Key Pharma News 16 FEBRUARY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


Download Unlimited Documents from Trusted Public Sources

The future of the Health Facility Industry in the US

  • February 2017
    9 pages
  • Health Facility  

    Nursing Home  

  • United States  

View report >

Opioid Market in the US

  • February 2017
    4 pages
  • Opioid  

  • United States  

View report >

Opioid Market in the US

  • February 2017
    4 pages
  • Opioid  

  • United States  

View report >

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.